Immunogenicity of a Fourth Homologous Dose of NVX-CoV2373

被引：15

作者：

Alves, Katia ^{[1
]}

Plested, Joyce S. ^{[1
]}

Galbiati, Shirley ^{[1
]}

Chau, Gordon ^{[1
]}

Cloney-Clark, Shane ^{[1
]}

Zhu, Mingzhu ^{[1
]}

Kalkeri, Raj ^{[1
]}

Patel, Nita ^{[1
]}

Smith, Kathy ^{[1
]}

Marcheschi, Alex ^{[1
]}

Pfeiffer, Susan ^{[1
]}

McFall, Heather ^{[1
]}

Smith, Gale ^{[1
]}

Glenn, Gregory M. ^{[1
]}

Dubovsky, Filip ^{[1
]}

Mallory, Raburn M. ^{[1
]}

机构：

[1] Novavax, Gaithersburg, MD 20878 USA

来源：

NEW ENGLAND JOURNAL OF MEDICINE | 2023年 / 388卷 / 09期

关键词：

D O I：

10.1056/NEJMc2215509

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Fourth Dose of SARS-CoV-2 Adjuvanted Protein VaccineBoosters of adjuvanted NVX-CoV2373 protein vaccine led to increasing neutralizing titers of antibody specific for the ancestral strain and omicron variants. Whether the elicited antibodies protect against infection is unclear.

引用

页码：857 / 859

页数：3

共 50 条

[1] Immunogenicity and safety of a fourth homologous dose of NVX-CoV2373
Alves, Katia
Plested, Joyce S.
Galbiati, Shirley
Chau, Gordon
Cloney-Clark, Shane
Zhu, Mingzhu
Kalkeri, Raj
Patel, Nita
Smith, Kathy
Marcheschi, Alex
Pfeiffer, Susan
McFall, Heather
Smith, Gale
Glenn, Gregory M.
Dubovsky, Filip
Mallory, Raburn M.
VACCINE, 2023, 41 (29) : 4280 - 4286
[2] Safety, efficacy, and immunogenicity of the NVX-CoV2373 vaccine
Underwood, Eddie
Dunkle, Lisa M.
Madhi, Shabir A.
Gay, Cynthia L.
Heath, Paul T.
Kotloff, Karen L.
Smith, Katherine
Chau, Gordon
Galbiati, Shirley
McGarry, Alice
Woo, Wayne
Cho, Iksung
Alves, Katia
Anez, German
Bennett, Chijioke
Shinde, Vivek
Fries, Louis
Mallory, Raburn M.
Glenn, Gregory M.
Toback, Seth
EXPERT REVIEW OF VACCINES, 2023, 22 (01) : 501 - 517
[3] Immunogenicity of NVX-CoV2373 heterologous boost against SARS-CoV-2 variants
Kirsten E. Lyke
Robert L. Atmar
Clara Dominguez Islas
Christine M. Posavad
Meagan E. Deming
Angela R. Branche
Christine Johnston
Hana M. El Sahly
Srilatha Edupuganti
Mark J. Mulligan
Lisa A. Jackson
Richard E. Rupp
Christina A. Rostad
Rhea N. Coler
Martín Bäcker
Angelica C. Kottkamp
Tara M. Babu
David Dobrzynski
Judith M. Martin
Rebecca C. Brady
Robert W. Frenck
Kumaravel Rajakumar
Karen Kotloff
Nadine Rouphael
Daniel Szydlo
Rahul PaulChoudhury
Janet I. Archer
Sonja Crandon
Brian Ingersoll
Amanda Eaton
Elizabeth R. Brown
M. Juliana McElrath
Kathleen M. Neuzil
David S. Stephens
Diane J. Post
Bob C. Lin
Leonid Serebryannyy
John H. Beigel
David C. Montefiori
Paul C. Roberts
npj Vaccines, 8
[4] Immunogenicity of NVX-CoV2373 heterologous boost against SARS-CoV-2 variants
Lyke, Kirsten E.
Atmar, Robert L.
Islas, Clara Dominguez
Posavad, Christine M.
Deming, Meagan E.
Branche, Angela R.
Johnston, Christine
El Sahly, Hana M.
Edupuganti, Srilatha
Mulligan, Mark J.
Jackson, Lisa A.
Rupp, Richard E.
Rostad, Christina A.
Coler, Rhea N.
Backer, Martin
Kottkamp, Angelica C.
Babu, Tara M.
Dobrzynski, David
Martin, Judith M.
Brady, Rebecca C.
Frenck Jr, Robert W.
Rajakumar, Kumaravel
Kotloff, Karen
Rouphael, Nadine
Szydlo, Daniel
PaulChoudhury, Rahul
Archer, Janet, I
Crandon, Sonja
Ingersoll, Brian
Eaton, Amanda
Brown, Elizabeth R.
McElrath, M. Juliana
Neuzil, Kathleen M.
Stephens, David S.
Post, Diane J.
Lin, Bob C.
Serebryannyy, Leonid
Beigel, John H.
Montefiori, David C.
Roberts, Paul C.
NPJ VACCINES, 2023, 8 (01)
[5] Immunogenicity and safety of NVX-CoV2373 as a booster: A phase 3 randomized clinical trial in adults
Raiser, Fritz
Davis, Matthew
Adelglass, Jeffrey
Cai, Miranda R.
Chau, Gordon
Cloney-Clark, Shane
Eickhoff, Mark
Kalkeri, Raj
McKnight, Irene
Plested, Joyce
Zhu, Mingzhu
Dunkle, Lisa M.
VACCINE, 2023, 41 (41) : 5965 - 5973
[6] SARS-CoV-2 spike glycoprotein vaccine candidate NVX-CoV2373 immunogenicity in baboons and protection in mice
Jing-Hui Tian
Nita Patel
Robert Haupt
Haixia Zhou
Stuart Weston
Holly Hammond
James Logue
Alyse D. Portnoff
James Norton
Mimi Guebre-Xabier
Bin Zhou
Kelsey Jacobson
Sonia Maciejewski
Rafia Khatoon
Malgorzata Wisniewska
Will Moffitt
Stefanie Kluepfel-Stahl
Betty Ekechukwu
James Papin
Sarathi Boddapati
C. Jason Wong
Pedro A. Piedra
Matthew B. Frieman
Michael J. Massare
Louis Fries
Karin Lövgren Bengtsson
Linda Stertman
Larry Ellingsworth
Gregory Glenn
Gale Smith
Nature Communications, 12
[7] SARS-CoV-2 spike glycoprotein vaccine candidate NVX-CoV2373 immunogenicity in baboons and protection in mice
Tian, Jing-Hui
Patel, Nita
Haupt, Robert
Zhou, Haixia
Weston, Stuart
Hammond, Holly
Logue, James
Portnoff, Alyse D.
Norton, James
Guebre-Xabier, Mimi
Zhou, Bin
Jacobson, Kelsey
Maciejewski, Sonia
Khatoon, Rafia
Wisniewska, Malgorzata
Moffitt, Will
Kluepfel-Stahl, Stefanie
Ekechukwu, Betty
Papin, James
Boddapati, Sarathi
Wong, C. Jason
Piedra, Pedro A.
Frieman, Matthew B.
Massare, Michael J.
Fries, Louis
Bengtsson, Karin Lovgren
Stertman, Linda
Ellingsworth, Larry
Glenn, Gregory
Smith, Gale
NATURE COMMUNICATIONS, 2021, 12 (01)
[8] Immunogenicity of two doses of the NVX-CoV2373 SARS-CoV-2 vaccine in comparison to homologous BNT162b and mRNA1273 regimens
Hielscher, F.
Schmidt, T.
Klemis, V.
Marx, S.
Abu-Omar, A.
Ziegler, L.
Guckelmus, C.
Urschel, R.
Sester, U.
Sester, M.
EUROPEAN JOURNAL OF IMMUNOLOGY, 2022, 52 : 166 - 167
[9] Novavax NVX-COV2373 triggers neutralization of Omicron sub-lineages
Jinal N. Bhiman
Simone I. Richardson
Bronwen E. Lambson
Prudence Kgagudi
Nonkululeko Mzindle
Haajira Kaldine
Carol Crowther
Glenda Gray
Linda-Gail Bekker
Vivek Shinde
Chijioke Bennett
Gregory M. Glenn
Shabir A. Madhi
Penny L. Moore
Scientific Reports, 13
[10] NVX-CoV2373, a protein subunit vaccine against SARS-CoV-2 infection
Vohra-Miller, Sabina
Schwartz, Ilan S.
CANADIAN MEDICAL ASSOCIATION JOURNAL, 2022, 194 (45) : E1554 - E1555

← 1 2 3 4 5 →